These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8810786)

  • 41. Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
    Takatsuki S; Mitamura H; Kanki H; Sueyoshi K; Ogawa S
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):914-8. PubMed ID: 10836726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?
    Szentmiklosi AJ; Szentandrássy N; Hegyi B; Horvath B; Magyar J; Bányász T; Nanasi PP
    Curr Pharm Des; 2015; 21(8):1030-41. PubMed ID: 25354180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empiric therapy with beta-blockers.
    Hjalmarson A
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):460-6. PubMed ID: 7513874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular arrhythmias in the elderly: evaluation and medical management.
    Leal MA; Field ME; Page RL
    Clin Geriatr Med; 2012 Nov; 28(4):665-77. PubMed ID: 23101576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic action of adrenergic beta-receptor blocking agents.
    Seth SD
    Pharmacol Ther; 1980; 11(1):159-79. PubMed ID: 6107939
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.
    Haverkamp W; Gülker H; Hindricks G; Breithardt G
    Basic Res Cardiol; 1990; 85 Suppl 1():293-303. PubMed ID: 1982610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of antiarrhythmic drug effects by beta-adrenergic sympathetic stimulation.
    Sager PT
    Am J Cardiol; 1998 Aug; 82(4A):20I-30I. PubMed ID: 9737651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophysiologic effects of beta blockers in ventricular arrhythmias.
    Venditti FJ; Garan H; Ruskin JN
    Am J Cardiol; 1987 Aug; 60(6):3D-9D. PubMed ID: 2888298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Is There Still a Need for Medical Antiarrhythmic Therapy?].
    Fischer TH
    Dtsch Med Wochenschr; 2020 Apr; 145(8):526-535. PubMed ID: 32294778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-blocker effectiveness post infarction: an antiarrhythmic or antiischemic effect.
    Hjalmarson A
    Ann N Y Acad Sci; 1984; 427():101-11. PubMed ID: 6146281
    [No Abstract]   [Full Text] [Related]  

  • 51. Beta-blocker therapy in patients with ventricular tachyarrhythmias in the setting of left ventricular dysfunction.
    Brodsky MA; Allen BJ; Bessen M; Luckett CR; Siddiqi R; Henry WL
    Am Heart J; 1988 Apr; 115(4):799-808. PubMed ID: 2895576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Revisiting established medical options - antiarrhythmic drugs and beta-blocker combinations.
    Obel OA
    Resuscitation; 2000 Aug; 45(3):S7-S10. PubMed ID: 10959028
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-Inflammatory and Antiarrhythmic Effects of Beta Blocker in a Rat Model of Rheumatoid Arthritis.
    Lin TT; Sung YL; Syu JY; Lin KY; Hsu HJ; Liao MT; Liu YB; Lin SF
    J Am Heart Assoc; 2020 Sep; 9(18):e016084. PubMed ID: 32865101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asymptomatic ventricular ectopy. To treat or not to treat?
    Lofgren RP; Hoppe RB
    Postgrad Med; 1983 Apr; 73(4):261-4, 267-71, 274. PubMed ID: 6132372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-adrenergic blocking drugs as antifibrillatory agents.
    Reiter MJ
    Curr Cardiol Rep; 2002 Sep; 4(5):426-33. PubMed ID: 12169240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
    Golikov AP; Orlov AI; Ivleva VI; Stepura OB
    Kardiologiia; 1980 Oct; 20(10):35-40. PubMed ID: 6108378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perspectives on the current treatment of cardiac arrhythmias.
    Bigger JT
    Am J Cardiol; 1984 Aug; 54(4):2B-7B. PubMed ID: 6147081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of a long acting beta-adrenoceptor blocker on diurnal variation of cardiac dysrhythmias.
    Mir MA
    Postgrad Med J; 1986 Mar; 62(725):175-8. PubMed ID: 2872664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II.
    Morgan PH; Mathison IW
    J Pharm Sci; 1976 May; 65(5):635-48. PubMed ID: 6770
    [No Abstract]   [Full Text] [Related]  

  • 60. [EFFICACY OF ANTIARRHYTHMIC AGENTS UNDER CONDITIONS OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM.].
    Popova EP; Fisenko VP
    Eksp Klin Farmakol; 2016; 79(11):26-34. PubMed ID: 29791106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.